- Filed
- Aug 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Aug 7, 2025 | 19.21M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 14.79M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 14.77M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 12.77M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 12.74M sh |
| Capex | Q2 2025 · Jun 30, 2025 | $414K |
| Capex | Q2 2025 · Jun 30, 2024 | $361K |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$89.2M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | −$80.11M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $98.8M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $105.6M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $133.42M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $298.92M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $336.52M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $382.82M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $566.5M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $603.16M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $654.95M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $36.9M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $53.79M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $86.53M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $108.04M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $282.21M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $379.59M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $385.45M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $490.86M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$2.89 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$6.42 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$3.59 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$8.36 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$2.89 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$6.42 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$3.59 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$8.36 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $9.79M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $23.83M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $12.26M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $25.75M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $34.86M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $78.3M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $40.26M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $83.44M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$42.68M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$94.88M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$45.81M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$106.48M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$47.14M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$104.51M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$51.53M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$107.1M |
| Revenue | Q2 2025 · Jun 30, 2025 | $8K |
| Revenue | Q2 2025 · Jun 30, 2025 | $15K |
| Revenue | Q2 2025 · Jun 30, 2024 | $13K |
| Revenue | Q2 2025 · Jun 30, 2024 | $16K |